ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...

Background Adverse childhood experiences (ACEs) are linked to poor health and social outcomes, with growing interest in their ...

Copper prices experienced a significant pullback this week with limited rebound, accumulating a decline of 1,400 yuan/mt. The price of bare bright copper in Guangdong was quoted at 77,800-78,000 ...

More than 50,000 children aged seven to 11 from every council area in Wales took part in the research. One in 10 reported ...

Secondary infertility, the struggle to conceive after a previous birth, is increasingly common among women aged 25-40.

Patients with severe hypertriglyceridemia have an increased risk of acute pancreatitis. The efficacy and safety of olezarsen, ...

Some people don’t lose enough weight after bariatric surgery, but a new study shows that adding a daily shot of GLP-1 drug ...

Chromosome compartment analysis of a cancer cell line cohort reveals different subsets of compartment changes where some track epithelial to mesenchymal transition while others reflect secondary ...

A new research paper was published in Oncotarget (Volume 16) on November 6, 2025, titled "LRIG1-3 in gliomas: LRIG1 protein expression decreased in higher grade gliomas." ...

In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

In this retrospective cohort study designed to assess long-term safety outcomes of drug-coated devices (DCDs) versus ...